文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

作者信息

Safi Najibullah, Davis Gary D, Nadir Mohammed, Hamid Hamida, Robert Leon L, Case Alan J

机构信息

Primary Health Care Department, World Health Organization Country Office, UNOCA Compound, Jalalabad Road, Kabul, Islamic Republic of Afghanistan.

出版信息

Mil Med. 2012 Mar;177(3):345-51. doi: 10.7205/milmed-d-11-00161.


DOI:10.7205/milmed-d-11-00161
PMID:22479925
Abstract

Anthroponotic cutaneous leishmaniasis (CL) is a common cause of ulcerative lesions and disfiguring scarring among children in Afghanistan. Most lesions occur on the face and are commonly caused by the trypanosome protozoan parasite Leishmania tropica, transmitted by the bite of an infected sandfly (Phlebotomus sergenti). This study compared the effectiveness of a single localized treatment with thermotherapy to 5 days of intralesional administration of Glucantime for the treatment of CL. Three hundred and eighty-two patients with CL were randomly assigned to the two treatment groups and followed for 6 months. The cure rate for the thermotherapy group was 82.5%, compared to 74% in the Glucantime group. The authors concluded that a single localized treatment with thermotherapy was more effective than 5 days of intralesional administration of Glucantime. Additionally, thermotherapy was more cost-effective, with fewer side effects, of shorter duration, and with better patient compliance than intralesional Glucantime.

摘要

相似文献

[1]
Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

Mil Med. 2012-3

[2]
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.

Int J Dermatol. 2004-4

[3]
Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.

J Eur Acad Dermatol Venereol. 2011-5

[4]
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.

Trials. 2012-5-17

[5]
Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.

J Infect Public Health. 2013-2-1

[6]
Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

Am J Trop Med Hyg. 2009-2

[7]
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.

Int J Dermatol. 2006-9

[8]
Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.

Acta Derm Venereol. 2024-4-29

[9]
Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.

Int J Dermatol. 2005-12

[10]
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.

J Dermatolog Treat. 2001-9

引用本文的文献

[1]
Cutaneous leishmaniasis in Afghanistan.

Trans R Soc Trop Med Hyg. 2025-8-8

[2]
Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review.

Trop Med Infect Dis. 2023-9-10

[3]
Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.

PLoS Negl Trop Dis. 2022-9

[4]
Health Status of Afghan Refugees in Europe: Policy and Practice Implications for an Optimised Healthcare.

Int J Environ Res Public Health. 2022-7-27

[5]
Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review.

Infect Dis Ther. 2022-4

[6]
Heat therapy for cutaneous leishmaniasis: A literature Review.

J Res Med Sci. 2021-2-27

[7]
Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.

PLoS Negl Trop Dis. 2021-1

[8]
Failure of an Innovative Low-Cost, Noninvasive Thermotherapy Device for Treating Cutaneous Leishmaniasis Caused by in Pakistan.

Am J Trop Med Hyg. 2019-12

[9]
Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Expert Opin Drug Metab Toxicol. 2019-6-17

[10]
A Functional Wound Dressing as a Potential Treatment for Cutaneous Leishmaniasis.

Pharmaceutics. 2019-5-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索